Variable | Level of variable | cORa (95% CIb) | P-value |
---|---|---|---|
Agec | 0.99 (0.97–1.01) | 0.80 | |
Sex | Male | 1 | – |
Female | 2.28 (1.22–4.26) | 0.01 | |
Marital status | Single | 1 | – |
Married | 1.05 (0.28–3.91) | 0.93 | |
Area of residence | Urban | 1 | – |
Rural | 0.87 (0.42–1.76) | 0.70 | |
Education level | Under diploma | 1 | – |
Diploma and more | 1.58 (0.84–2.97) | 0.15 | |
Cancer site | Breast | 1 | – |
Gastrointestinal | 0.09 (0.03–0.24) |  ≤ 0.0001 | |
Lymphoma and hematologic tumors | 0.31 (0.10–0.91) | 0.03 | |
Gynecologic | 0.69 (0.07–6.27) | 0.74 | |
Thorax | 0.33 (0.10–1.07) | 0.06 | |
Other sites | 0.20 (0.04–0.95) | 0.04 | |
Clinical stage | I | 1 | – |
II | 2.5 (0.70–8.92) | 0.15 | |
III | 2.16 (0.64–7.33) | 0.21 | |
IV | 4.12 (0.98–17.19) | 0.05 | |
Unclear | 1.58 (0.54–4.62) | 0.39 | |
Metastatic status | Negative | 1 | – |
Positive | 1.25 (0.67–2.34) | 0.46 | |
Unclear | 0.27 (0.05–1.43) | 0.12 | |
Recurrence status | Negative | 1 | – |
Positive | 1.39 (0.58–3.34) | 0.45 | |
Unclear | 0.19 (0.04–0.89) | 0.03 | |
Comorbid illness | Negative | 1 | – |
Positive | 1.37 (0.75–2.51) | 0.29 | |
Nausea and vomiting | Negative | 1 | – |
Positive | 1.77 (0.94–3.31) | 0.07 | |
Constipation and diarrhea | Negative | 1 | – |
Positive | 1.08 (0.58–2.02) | 0.79 | |
Pain | Negative | 1 | – |
Positive | 3.16 (1.70–5.87) |  ≤ 0.0001 | |
Oral lesions | Negative | 1 | – |
Positive | 1.66 (0.90–3.06) | 0.10 | |
Skin lesions | Negative | 1 | – |
Positive | 1.35 (0.73–2.46) | 0.32 | |
Number of chemotherapeutic agentsc | 1.75 (1.40–2.19) |  ≤ 0.0001 | |
Number of herbal medicinesc | 1.12 (1.05–1.20) |  ≤ 0.0001 |